4 weeks HC Wainwright Reaffirms “Buy” Rating for Rigel Pharmaceuticals (NASDAQ:RIGL)MarketBeat
HC Wainwright reissued a “buy” rating and set a $57.00 price target on shares of Rigel Pharmaceuticals in a research report on Friday.
Nasdaq 100 · Pharmaceuticals · Science
X